ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 3 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $36.3M
- Insider buysLast 90 days, $134.7K in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 27
- 13F valueReported value at the end of Q2 2026
- $84.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$39.7M
- −1,529.3% year over year
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q2 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 245.8K
- Shares sold short
- Change
- +7.25K
- +3.0% vs. previous
- Days to cover
- 7.14
- At average daily volume
Superinvestors holding PMN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding PMN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by ProMIS Neurosciences Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)8:15 AM ET | Nov 4 | 2 days | Williams EugeneDirector | PPurchase | +26.5K | $3.43 | +$90.9K | +193.2%40.2K after | |
| Nov 3, 2026 (view filing)8:28 AM ET | Oct 30 | 4 days | Williams EugeneDirector | PPurchase | +1.32K | $3.99 | +$5.25K | +10.6%13.7K after | |
| Nov 3, 2026 (view filing)8:26 AM ET | Nov 2 | 1 day | Cashman NeilChief Scientific Officer | PPurchase | +10.0K | $3.86 | +$38.6K | +220.7%14.5K after | |
| Aug 7, 2026 (view filing)4:00 PM ET | Aug 5 | 2 days | Kaplan JohanneChief Development Officer | PPurchase | +2.28K | $13.30 | +$30.3K | +57.9%6.22K after | |
| Apr 23, 2026 (view filing) | Apr 22 | 1 day | Kirwin Patrick D.Director | PPurchase | +4.00K | $11.33 | +$45.3K | +612.6%4.65K after | |
| Mar 6, 2026 (view filing) | Mar 5 | 1 day | Williams EugeneDirector | PPurchase | +2.00K | $24.40 | +$48.8K | +19.2%12.4K after | |
| Mar 4, 2026 (view filing) | Mar 2-4 | 2 days | Williams EugeneDirector | PPurchase | +4.00K | $23.11 | +$92.4K | +62.5%10.4K after | 3 lots |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Kaplan JohanneChief Development Officer | PPurchase | +1.63K | $15.35 | +$25.0K | +70.5%3.94K after | |
| Feb 5, 2026 (view filing)7:00 PM ET | Feb 3 | 2 days | Alex Slanix Paul and 4 othersDirector | PPurchase | +700.7K | $12.13 | +$8.50M | +289.1%943.1K after | |
| Feb 5, 2026 (view filing)7:00 PM ET | Feb 3 | 2 days | Alex Slanix Paul and 4 othersDirector | PPurchase | +700.7K | – | – | –700.7K after | Derivative |
Top 10 13F holders, Q2 2026
See all 27 holdersThe largest institutional positions in ProMIS Neurosciences Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 1,292,757 | $17.0M | 0.01% | +1,292,757 | New |
| Deep Track Capital, LP | 835,655 | $11.0M | 0.16% | 00.0% | Unchanged |
| Wellington Management Group LLP | 696,378 | $9.16M | 0.00% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 620,319 | $8.16M | 10.52% | +206,100+49.8% | Added |
| Trails Edge Capital Partners, LP | 557,103 | $7.33M | 1.16% | 00.0% | Unchanged |
| Woodline Partners LP | 441,911 | $5.82M | 0.02% | +46,616+11.8% | Added |
| Fan Yu | 329,760 | $4.34M | 4.02% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 325,591 | $4.28M | 0.61% | 00.0% | Unchanged |
| Squadron Capital Management LLC | 324,977 | $4.28M | 1.46% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 205,000 | $2.70M | 0.44% | +150,000+272.7% | Added |
Holders of 5% or more of PMN
See all 10 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of ProMIS Neurosciences Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ABG Management Ltd. | 13D/A | 17.00%1.64M shares | +5.70 ppfrom 11.30% | Aug 4, 20254 filings | Feb 5, 2026 | SEC |
| Sclar Jeremy M. | 13G/A | 16.90%9.51M shares | – | Feb 3, 20235 filings | Oct 15, 2025 | SEC |
| Janus Henderson Group PLC | 13G | 14.40%1.29M shares | New | Apr 7, 20261 filing | Apr 7, 2026 | SEC |
| Shaf QIC LLC | 13G/A | 10.01%10.5M shares | – | Oct 16, 20242 filings | Jul 31, 2025 | SEC |
| Deep Track Capital, LP | 13G | 9.99%902.6K shares | New | Feb 6, 20261 filing | Feb 6, 2026 | SEC |